http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03062417-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a664bedd9998eb8e6618de433012081f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b5917d7e4514f41f66ffc21b1ef6960
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c8d4dc7bd1a30d8fda907fceaeb4e69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92ed85b09f8a8742c4b351ace32a9c29
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1062
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
filingDate 2003-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8909b8264974cd7ec5b630416f60177f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a424c07ea6c71e6af317e6083578ad6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80e8629aa46d00d24d6e8a3f26e0019a
publicationDate 2003-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03062417-A1
titleOfInvention Rna-dna ligation product and utilization thereof
abstract A method of ligating nucleic acids characterized in that a single-stranded RNA and a single-stranded DNA, which have sequences complementary to each other, are annealed and then treated with an RNA ligase; a nucleic acid construct which is bonded to a target mRNA and then translated so as to give a ligation product of the target mRNA to a protein encoded thereby; a method of screening a nucleic acid and/or a protein using a ligation product of a target mRNA and a protein encoded thereby; a puromycin derivative subjected to the final deblocking by an enzyme reaction; a carrier protein useful in functionally expressing a target peptide or a target protein having relatively short amino acid residues (for example, a peptide library made up of random sequences) in a cell-free translation system; and a method of ligating two single-stranded or double-stranded DNAs, which have sequences complementary to each other and are in different types, in the absence of any primers. Thus, it becomes possible to synthesize an in vitro virus genome, which can be produced at only a poor efficiency by the conventional methods, within a short period of time at a high efficiency.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9284600-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10669538-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11702652-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9121110-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9574189-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11118215-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8932992-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11225655-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11001835-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10077440-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9109248-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10731151-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096951-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10730906-B2
priorityDate 2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002291491-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002265492-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H1171392-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003070482-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0000632-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136301090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439530

Total number of triples: 38.